NCT05244122View on ClinicalTrials.gov

PROJECT 2 EXAMPLE: Feedback X Prevalence Using Dermatology Stimuli

NACompletedINTERVENTIONAL
Enrollment

1,121

Participants

Timeline

Start Date

June 22, 2021

Primary Completion Date

June 27, 2021

Study Completion Date

June 27, 2021

Conditions
Decision Making
Interventions
BEHAVIORAL

Feedback

presence or absence of trial by trial feedback

BEHAVIORAL

Prevalence

"In some blocks, skin cancer target images were present on 50% of trials (high prevalence). In other blocks, disease prevalence was 20%."

Trial Locations (1)

02215

Visual Attention Lab, Brigham and Women's Hospital, Boston

All Listed Sponsors
lead

Brigham and Women's Hospital

OTHER